CELL PROLIFERATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2020-05-21 txsyzu_32760595

4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表::
现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表:
现在很难投了，好多不送审直接毙掉哎

jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎

138 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-07-18 meww 来自江苏省

审稿速度:3.0
偏重的研究方向：发育;口腔
经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯

52 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-07-27 ms1000000907051820 来自河南

请问系统出现ADM:…, under review是送审了吗？

69 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-08-08 ms5000001215794688 来自北京

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：药物递送
经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。

155 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-08-16 ms5000001191279198 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：干细胞;再生;发育
经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-08-23 ms7000000339495981 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：代谢;干细胞;再生
经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-08-16 ms5000001191279198 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：干细胞;再生;发育
经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！

0 0

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-08-13 ms8000001022390356 来自北京

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;单细胞;类器官
经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！

68 0

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-08-12 ms3000000226534790 来自北京

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;类器官;代谢
经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？

101 0

[GetPortalCommentsPageByObjectIdResponse(id=591410, encodeId=0fa4591410b7, content=4月29日提交，5月20日awaiting EIC decision, 是不是被拒的可能很大？或者其他人有这情况？jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎jack123123 2020-05-18 00:00:00 发表: 现在很难投了，好多不送审直接毙掉哎, beContent=jack123123 2020-05-18 发表:: 现在很难投了，好多不送审直接毙掉哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2219106, encodeId=3b11221910612, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药物递送 经验分享：效率挺高的，2个多月给了小修，reviewer中只有一个比较难搞，要求补了不少。编辑回复很专业迅速，也给了一些好的建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e5e9416210, createdName=ms5000001215794688, createdTime=Thu Aug 08 11:59:19 CST 2024, time=2024-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220562, encodeId=989b22205620f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：审稿速度快，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:21:49 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222013, encodeId=5431222201399, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：代谢;干细胞;再生 经验分享：非常好的期刊！编辑和审稿人都特别负责，送审速度很快。强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5e09425292, createdName=ms7000000339495981, createdTime=Fri Aug 23 09:40:38 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220561, encodeId=3977222056196, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;再生;发育 经验分享：投稿周期短，编辑和审稿人给的意见都很专业。国产期刊之光！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7b89425452, createdName=ms5000001191279198, createdTime=Fri Aug 16 17:16:58 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219928, encodeId=921622199282a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;单细胞;类器官 经验分享：总体投稿经历较波折，修回了很多实验，不过幸好最终收到了好的结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6abd9200994, createdName=ms8000001022390356, createdTime=Tue Aug 13 16:50:18 CST 2024, time=2024-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2219687, encodeId=aac0221968edf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;类器官;代谢 经验分享：刚接收一篇，感觉编委和审稿人都挺专业的，有些黑子是被拒稿了心里不平衡吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Mon Aug 12 10:13:21 CST 2024, time=2024-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2023-09-19 ms8000000172957012 来自香港

偏重的研究方向：发育
经验分享：投稿的友友们，
我是9.17 投稿
9.18 分配编辑
9.19 Under review
我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~

122 13

展开13条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务